nach oben

European Journal of Nutrition

Erschienen in:

01.06.2014 | Original Contribution

Adipose tissue fatty acid composition and colon cancer: a case–control study

verfasst von: A. Giuliani, F. Ferrara, M. Scimò, F. Angelico, L. Olivieri, L. Basso

Erschienen in: European Journal of Nutrition | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

An increased dietary intake of fat, particularly polyunsaturated fatty acids (PUFAs), has been related to an increased risk of breast, prostate and colon cancers. Patients with and without colon cancer were tested for differences in their fatty stores composition.

Methods

The fatty acid levels were determined by gas–liquid chromatography in adipose tissue samples, subcutaneous and visceral, obtained intra-operatively from 52 colon cancer and 50 nonneoplastic abdominal disease patients. Statistical analysis was performed using one-way ANOVA, SNK test and Dunnet test. Differences in the composition of saturated, monounsaturated and polyunsaturated fatty acids, in visceral and in subcutaneous samples of colon cancer and nonneoplastic patients, were assessed.

Results

The sum of saturated and monounsaturated fatty acids, respectively, in visceral and in subcutaneous samples, was higher in neoplastic patients (p < 0.001). The sum of some n-6 polyunsaturated fatty acids (PUFAs), the dietary precursor linoleic acid (LA-18:2n-6), and their metabolites, gammalinolenic acid (GLA-18:3n-6) + dihomogammalinolenic acid (DGLA-20:3n-6) + arachidonic acid (AA-22:4n-6), was higher in subcutaneous fat of controls (p < 0.05). The samples from these patients had a fatty acid composition, both subcutaneous and visceral, with a higher content of alphalinolenic acid (ALA-18:3n-3) and stearidonic acid (SDA-18:4n-3) compared to neoplastic patients (p < 0.001). These had subcutaneous and visceral fat stores statistically higher in GLA, DGLA and AA (p < 0.001). Colon cancer patients had subcutaneous adipose stores higher in ALA and LA than visceral sites (p < 0.001).

Conclusions

Fatty acids may be involved in colon carcinogenesis and there is a depot-specific impact on this process by visceral fat.

Theodoratou E, McNeill G, Cetnarskyi R, Farrington SM, Tenesa A, Barnetson R, Porteous M, Dunlop M, Campbell H (2007) Dietary fatty acids and colorectal cancer: a case-control study. Am J Epidemiol 166:181–195CrossRef

Jones R, Adel-Alvarez LA, Alvarez OR, Broaddus R, Das S (2003) Arachidonic acid and colorectal carcinogenesis. Mol Cell Biochem 253:141–149CrossRef

Tsai WS, Nagawa H, Kaizaki S, Tsuruo T, Muto T (1968) Inhibitory effects of n-3 polyunsaturated fatty acids on sigmoid colon cancer transformants. J Gastroenterol 33:206–212CrossRef

Boudreau MD, Sohn KH, Rhee SH, Lee SW, Hunt JD, Hwang DH (2001) Suppression of tumor cell growth in nude mice and in culture by n-3 polyunsaturated fatty acids: mediation through cyclooxygenase-independent pathways. Cancer Res 61:1386–1391

Kohlmeier L, Mendez M (1997) Controversies surrounding diet and breast cancer. Proc Nutr Soc 56:369–382CrossRef

Field CJ, Clandinin MT (1984) Modulation of adipose tissue fat composition by diet: a review. Nutr Res 4:743–755CrossRef

Field JC, Angel A, Clandinin MT (1985) Relationship of diet to the fatty acid composition of human adipose tissue structural and stored lipid. Am J Clin Nutr 42:1206–1220

Baylin A, Kabagambe E, Siles X, Campos H (2002) Adipose tissue biomarkers of fatty acid intake. Am J Clin Nutr 76:750–757

Lands WE (1995) Long-term fat intake and biomarkers. Am J Clin Nutr 61(3):721S–725S

10.

Kohlmeier L, Simonsen N, Van’t Veer P, Strain JJ, Martin-Moreno JM, Margolin B, Huttunen JK, Fernandez-Crehuet Navajas J, Martin BC, Thamm M, Kardinaal AFM, Kok FJ (1997) Adipose tissue trans fatty acids and breast cancer in the European Community multicenter study on antioxidants, myocardial infarction, and breast cancer. Cancer Epidemiol Biomarkers Prev 6:705–710

11.

Simonsen N, Van’t Veer P, Strain JJ, Martin-Moreno JM, Huttunen JK, Fernandez-Crehuet Navajas J, Martin BC, Thamm M, Kardinaal AFM, Kok FJ, Kohlmeier L (1998) Adipose tissue omega-3 and omega-& fatty acid content and breast cancer in the EURAMIC study. Am J Epidemiol 147:342–352CrossRef

12.

Busstra MC, Siezen CL, Grubben MJ, Van Kranen HJ, Nagengast FM, Van’t Veer P (2003) Tissue level of fish oil fatty acids and risk of colorectal adenomas: a case-control study (Netherlands). Cancer Causes Control 14:269–276CrossRef

13.

Sass DA, Schoen RE, Weissfeld JL, Weissfeld L, Thaete L, Kuller LH, McAdams M, Lanza E, Schatzkin A (2004) Relationship of visceral adipose tissue to recurrence of adenomatous polyps. Am J Gastroenterol 99:687–693CrossRef

14.

Wynder EL, Kajitani T, Ishikawa S, Dodo H, Takano A (1969) Environmental factors of cancer of the colon and rectum II. Japanese epidemiological data. Cancer 23:1210–1220CrossRef

15.

Howe GR, Arinson KJ, Benito E, Castelletto R, Cornée J, Duffy S, Gallagher RP, Iscovich JM, Deng-ao J et al (1997) The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 8:215–228CrossRef

16.

Tsai WS, Nagawa H, Kaizaki S, Tsuruo T, Muto T (1998) Inhibitory effects of n-3 polyunsaturated fatty acids on sigmoid colon cancer transformants. J Gastroenterol 33:206–212CrossRef

17.

Nkondjock A, Shatenstein B, Maisonneuve P, Ghadirian P (2003) Specific fatty acids and human colorectal cancer: an overview. Cancer Detect Prev 27:55–66CrossRef

18.

Maillard V, Bougnoux P, Ferrari P, Jourdan ML, Pinault M, Lavillonnière F, Body G, Le Floch O, Chajés V (2002) N-3 and N-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. Int J Cancer 98:78–83CrossRef

19.

Kuruki K, Mutoh M, Tajima K, Wakabayashi K, Tatematsu M (2008) Relationships between intestinal polyps formation and fatty acid levels in plasma, erythrocytes, and intestinal polyps in Min mice. Cancer Sci 99:2410–2416CrossRef

20.

Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC (1994) Intake of fat, meat and fiber in relation to risk of colon cancer in men. Cancer Res 54:2390–2397

21.

Norat T, Riboli E (2001) Meat consumption and colorectal cancer: a review of epidemiologic evidence. Nutr Rev 59:37–47CrossRef

22.

Simopoulos AP, Leaf A, Salem N Jr (1999) Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr 18:487–489CrossRef

23.

Simopoulos AP (2000) Human requirement for N-3 polyunsaturated fatty acids. Poult Sci 79:961–970CrossRef

24.

de la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4:769–780CrossRef

25.

Narisawa T, Fukaura Y, Yazawa K, Ishikawa C, Isoda Y, Nishizawa Y (1994) Colon cancer prevention with a small amount of dietary perilla oil high in alpha-linolenic acid in animal model. Cancer 73:2069–2075CrossRef

26.

Onigi N, Okuno M, Komaki C, Moriwaki H, Kawamori T, Tanaka T, Mori H, Muto Y (1996) Suppressing effect of perilla oil on azoxymethane-induced foci of colonic aberrant crypts in rats. Carcinogenesis 17:1291–1296CrossRef

27.

Larsson SC, Kumlin M, Ingelman-Sundberg M (2004) Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79:935–945

28.

Crawford MA, Doyle W, Williams G, Drucy PJ (1989) The role of fats and EFAs for energy and cell structure in growth of the fetus and neonate. In: Vergroesen AJ, Crawford MA (eds) The role of fat in human nutrition, 2nd edn. Academic Press, New York, pp 81–115CrossRef

29.

Hansen Petric MB, McEntee MF, Johnson BT, Obukowicz MG, Whelan J (2000) Highly unsaturated (n-3) fatty acids, but not α-linolenic, conjugated linolenic or γ-linolenic acids, reduce tumorigenesis in Apc Min ^/+ mice. J Nutr 130:2434–2443

30.

Roynette CE, Calder PhC, Dupertuis YM, Pichard C (2004) N-3 polyunsaturated fatty acids and colon cancer prevention. Clin Nutr 23:139–151CrossRef

31.

Wendum D, Masliah J, Trugnan G, Fléjou JF (2004) Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch 445:327–333CrossRef

32.

Jones R, Adel-Alvarez LA, Alvarez OR, Broaddus R, Das S (2003) Arachidonic acid and colorectal carcinogenesis. Mol Cell Biochem 253:141–149CrossRef

33.

Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, Pasternach GR, Kuhajda FP, Hamilton SR (1997) Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal cancer. Am J Pathol 150:201–208

34.

Kuhajda FP (2000) Fatty-Acid Synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16:202–208CrossRef

35.

Frezza EE, Wachtel MS, Chiriva-Internati M (2006) Influence of obesity on the risk of developing colon cancer. Gut 55:285–291CrossRef

36.

Renehan A, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578CrossRef

Titel: Adipose tissue fatty acid composition and colon cancer: a case–control study
verfasst von: A. Giuliani
F. Ferrara
M. Scimò
F. Angelico
L. Olivieri
L. Basso
Publikationsdatum: 01.06.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 4/2014
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-013-0605-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Pubertal supplementation of lipotropes in female rats reduces mammary cancer risk by suppressing histone deacetylase 1

Comparative evaluation of cow β-casein variants (A1/A2) consumption on Th2-mediated inflammatory response in mouse gut

Changes in body anthropometry and composition in obese adolescents in a lifestyle intervention program

Effects of a healthy Nordic diet on plasma 25-hydroxyvitamin D concentration in subjects with metabolic syndrome: a randomized, placebo-controlled trial (SYSDIET)

Vitamin D is not linked to folate status and mRNA expression of intestinal proton-coupled folate transporter